UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interruptions in emergency department work: an observational and interview study

BMJ quality & safety, 2013-08, Vol.22 (8), p.656-663

2013

Volltextzugriff (PDF)

Predictors of mortality and morbidity in patients with chronic heart failure

European heart journal, 2006-01, Vol.27 (1), p.65-75

2006

Volltextzugriff (PDF)

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure

European heart journal, 2008-06, Vol.29 (11), p.1377-1385

2008

Volltextzugriff (PDF)

High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm

Blood pressure, 2018-09, Vol.27 (5), p.249-255

2018

Volltextzugriff (PDF)

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

The Lancet (British edition), 2005-09, Vol.366 (9489), p.895-906

2005

Volltextzugriff (PDF)

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913

2005

Volltextzugriff (PDF)

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

European heart journal, 2008-06, Vol.29 (11), p.1377-1385

2008

Volltextzugriff (PDF)

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

The Lancet (British edition), 2003-09, Vol.362 (9386), p.777-781

2003

Volltextzugriff (PDF)

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

The Lancet (British edition), 2003-09, Vol.362 (9386), p.759-766

2003

Volltextzugriff (PDF)

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

The Lancet (British edition), 2003-09, Vol.362 (9386), p.767-771

2003

Volltextzugriff (PDF)

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

The Lancet (British edition), 2003-09, Vol.362 (9386), p.772-776

2003

Volltextzugriff (PDF)

Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES

Journal of the American College of Cardiology, 2007-02, Vol.49 (6), p.687-694

2007

Volltextzugriff (PDF)

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

The Lancet (British edition), 2003-04, Vol.361 (9364), p.1149-1158

2003

Volltextzugriff (PDF)

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

European heart journal, 2008-11, Vol.29 (21), p.2641-2650

2008

Volltextzugriff (PDF)

Systolic blood pressure increases in patients with atrial fibrillation regaining sinus rhythm after electrical cardioversion

The journal of clinical hypertension (Greenwich, Conn.), 2019-03, Vol.21 (3), p.363-368

2019

Volltextzugriff (PDF)

Physicians’ and nurses’ perceptions of patient safety risks in the emergency department

International emergency nursing, 2017-07, Vol.33, p.14-19

2017

Volltextzugriff (PDF)

Significant changes in emergency department length of stay and case mix over eight years at a large Swedish University Hospital

International emergency nursing, 2019-03, Vol.43, p.50-55

2019

Volltextzugriff (PDF)

Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial

European heart journal, 2006-12, Vol.27 (24), p.2982

2006

Volltextzugriff (PDF)

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Diabetes care, 2009-05, Vol.32 (5), p.915-920

2009

Volltextzugriff (PDF)

Amino-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein but Not Cystatin C Predict Cardiovascular Events in Male Patients with Peripheral Artery Disease Independently of Ambulatory Pulse Pressure

American journal of hypertension, 2014-03, Vol.27 (3), p.363-371

2014

Volltextzugriff (PDF)

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure

European heart journal, 2008-02, Vol.29 (4), p.499-508

2008

Volltextzugriff (PDF)

Contributing factors to errors in Swedish emergency departments

International emergency nursing, 2015-04, Vol.23 (2), p.156-161

2015

Volltextzugriff (PDF)

Improvement of blood pressure control and physicians' management over time in patients with coronary artery disease

Blood pressure, 2016-10, Vol.25 (5), p.286-291

2016

Volltextzugriff (PDF)

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease

Annals of medicine (Helsinki), 2012-05, Vol.44 (3), p.262-270

2012

Volltextzugriff (PDF)

Sommarrapport från en skånsk by

Läkartidningen, 2016-07, Vol.113

Östergren, Jan

2016

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(156)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(77)
Life Sciences & Biomedicine
(75)
Science & Technology
(75)
Medicin Och Hälsovetenskap
(65)
Male
(53)
Female
(51)
Middle Aged
(45)
Aged
(40)
Biological And Medical Sciences
(36)
Medical Sciences
(35)
Adult
(31)
Cardiovascular System & Cardiology
(31)
Risk Factors
(26)
Hypertension
(20)
Blood Pressure
(17)
Cardiac & Cardiovascular Systems
(17)
Cardiology. Vascular System
(16)
Heart
(16)
Antihypertensive Agents - Therapeutic Use
(15)
General & Internal Medicine
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interruptions in emergency department work: an observational and interview study

Predictors of mortality and morbidity in patients with chronic heart failure

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure

High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

Systolic blood pressure increases in patients with atrial fibrillation regaining sinus rhythm after electrical cardioversion

Physicians’ and nurses’ perceptions of patient safety risks in the emergency department

Significant changes in emergency department length of stay and case mix over eight years at a large Swedish University Hospital

Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Amino-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein but Not Cystatin C Predict Cardiovascular Events in Male Patients with Peripheral Artery Disease Independently of Ambulatory Pulse Pressure

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure

Contributing factors to errors in Swedish emergency departments

Improvement of blood pressure control and physicians' management over time in patients with coronary artery disease

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease

Sommarrapport från en skånsk by

Aktive Filter

Suchergebnisse filtern